U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07946731) titled 'Imprinting in Metabolic Diseases - Identifying Epigenetic Mechanisms in Human Gestational Diabetes Through Cell-free DNA - Part B' on Nov. 12.
Brief Summary: This clinical trial aims to investigate the development of and changes in fetal epigenetic signatures and how maternal metabolism influences these.
The metabolic profiles of the mother will be evaluated at three timepoints during pregnancy from a fasting blood sample and at another timepoints from an oral glucose tolerance test. Fetal epigenetic signatures can be identified by analyzing fetal cell-free DNA that circulates in the mother's bloodstream.
Study Start Date: Jan. 01...